Crucible Therapeutics

Developer of RNA-targeting therapies for neurodegenerative diseases

placeSheffield, England, United Kingdom calendar_todayFounded 2023 language crucible-tx.com

Innovation

3 patent families — focus: Chemistry & metallurgy; filing pace active. Cited 15 times.

YearFilings
20242
20251
20261

Social engagement

Social engagement: 873 social following, 2 posts in the last 12 months — below the industry typical range.

Investor mix

1 investor on record.

Investor typeCountShare
Other / undisclosed1100%

Recent activity

28 Oct 2025
Leadership hire
Chief Executive Officer
Coming soon